Edgewise Therapeutics(EWTX)
BOULDER, CO
BiotechnologyFocus: Small Molecules for Musculoskeletal Diseases
Edgewise Therapeutics is a life sciences company focused on Small Molecules for Musculoskeletal Diseases.
Musculoskeletal
Funding Stage
PUBLIC
Open Jobs
19
Pipeline & Clinical Trials
Defining Endpoints in Becker Muscular Dystrophy
Becker Muscular DystrophyClinical Trials (1)
NCT05257473Defining Endpoints in Becker Muscular Dystrophy
N/AFast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
Becker Muscular DystrophyClinical Trials (1)
NCT04349566Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
N/AEDG-7500
Hepatic Impairment (HI)Clinical Trials (1)
NCT07324616A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment
Phase 1EDG-7500
Healthy Adult ParticipantsClinical Trials (1)
NCT07456059A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults
Phase 1[14C]-EDG-7500
Healthy VolunteerClinical Trials (1)
NCT06738836A Study to Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C]-EDG-7500
Phase 1EDG-5506
Healthy VolunteerClinical Trials (1)
NCT04585464A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults
Phase 1EDG-15400
Healthy AdultsClinical Trials (1)
NCT07177066A Study of EDG-15400 in Healthy Adults
Phase 1EDG-5506
Muscular DystrophiesClinical Trials (1)
NCT05492734A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling
Phase 1EDG-7500
Healthy SubjectsClinical Trials (1)
NCT06011317A Study of EDG-7500 in Healthy Adults
Phase 1EDG-7500
Renal ImpairmentsClinical Trials (1)
NCT07034768A Study to Evaluate EDG-7500 in People With Renal Impairment
Phase 1Sevasemten
Becker Muscular DystrophyClinical Trials (1)
NCT05160415A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
Phase 1sevasemten
Healthy SubjectsClinical Trials (1)
NCT06916897A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers
Phase 1EDG-5506 Tablet
Healthy VolunteerClinical Trials (1)
NCT05730842Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers
Phase 1EDG-7500
Hypertrophic CardiomyopathyClinical Trials (1)
NCT06347159A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
Phase 2Sevasemten Dose 1
Duchenne Muscular DystrophyClinical Trials (1)
NCT05540860A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
Phase 2Sevasemten
Becker Muscular DystrophyClinical Trials (1)
NCT06066580Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Phase 2Sevasemten Dose 1
Duchenne Muscular DystrophyClinical Trials (1)
NCT06100887Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy
Phase 2Sevasemten 10 mg
Becker Muscular DystrophyClinical Trials (1)
NCT05291091Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Phase 2Open Jobs (19)
Associate Director/Director, Regulatory Affairs (EDG-2026016)
All US
Regulatory Affairs2w ago
Medical Science Liaison/Senior MSL/Executive MSL – West - (EDG-2026012)
All US
Medical Affairs2w ago
Medical Science Liaison/Senior MSL/Executive MSL – Southeast (EDG-2026009)
All US
Medical Affairs2w ago
Medical Science Liaison/Senior MSL/Executive MSL – Northeast (EDG-2026011)
All US
Medical Affairs2w ago
Medical Science Liaison/Senior MSL/Executive MSL – North Central (EDG-2026013)
All US
Medical Affairs2w ago
Medical Science Liaison/Senior MSL/Executive MSL – Mid-Atlantic (EDG-2026010)
All US
Medical Affairs2w ago
Vice President, Marketing - Sevasemten (EDG-2026017)
All US
Commercial2w ago
Senior Director/Executive Director, Insights and Analytics (EDG-2026018)
All US
Commercial2w ago
Senior Director, Payer Accounts – UnitedHealth Group (EDG-2026003)
All US
Commercial2w ago
Senior Director, Payer Accounts – CVS Health (EDG-2026005)
All US
Commercial2w ago
Senior Director, Payer Accounts – Cigna Group (EDG-2026004)
All US
Commercial2w ago
Senior Clinical Research Associate - Cardiovascular (EDG-2025017)
Boulder, CO
Clinical Development2w ago
Senior Manager/Associate Director, Clinical Operations (EDG-2026002)
All US
Clinical Development2w ago
Medical Director/Clinical Development Physician – Musculoskeletal (EDG-2026007)
All US
Clinical Development2w ago
Executive Director, Drug Safety & Pharmacovigilance (EDG-2026015)
All US
Clinical Development2w ago
Executive Director, Cardiovascular Clinical Development (EDG-2025068)
All US
Clinical Development2w ago
Clinical Contracts Administrator (EDG-2026019)
All US
Clinical Development2w ago
Associate Director, Pharmaceutical Development (EDG-2026008)
All US
Chemistry, Manufacturing and Controls2w ago
Senior Manager/Associate Director, Regulatory Affairs CMC (EDG-2026020)
Remote
Regulatory Affairs1y ago
$150K - $210K/yr
Interview Prep Quick Facts
Portfolio: 18 clinical trials
Top TAs: Rare Diseases, Cardiovascular, Gastroenterology
SEC Filings: 2 available
Open Roles: 19 active jobs
Therapeutic Area Focus
Marketed
Pipeline